KD Logo

Robert W. Baird upgrades Dexcom Inc (DXCM) stock to an Outperform

In a filing, Dexcom Inc revealed its EVP, Chief Financal Officer Sylvain Jereme M unloaded Company’s shares for reported $0.18 million on Jan 29 ’25. In the deal valued at $86.91 per share,2,090 shares were sold. As a result of this transaction, Sylvain Jereme M now holds 83,526 shares worth roughly $7.25 million.

Then, Dolan Matthew Vincent sold 1,183 shares, generating $102,820 in total proceeds. Upon selling the shares at $86.91, the EVP, Strategy & Corporate Dev now owns 42,044 shares.

Before that, Stern Sadie sold 2,093 shares. Dexcom Inc shares valued at $181,911 were divested by the EVP, Chief HR Officer at a price of $86.91 per share. As a result of the transaction, Stern Sadie now holds 74,261 shares, worth roughly $6.45 million.

Robert W. Baird upgraded its Dexcom Inc [DXCM] rating to an Outperform from a a Neutral in a research note published on January 16, 2025; the price target was increased to $104 from $86. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who decreased its forecast for the stock in late July from “an Outperform” to “a Neutral”. JP Morgan also remained covering DXCM and has decreased its forecast on July 26, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Redburn Atlantic started covering the stock on May 30, 2024. It rated DXCM as “a Neutral”.

Price Performance Review of DXCM

On Friday, Dexcom Inc [NASDAQ:DXCM] saw its stock fall -0.90% to $86.83. Over the last five days, the stock has lost -2.16%. Dexcom Inc shares have risen nearly 11.65% since the year began. Nevertheless, the stocks have fallen -28.11% over the past one year. While a 52-week high of $142.00 was reached on 01/27/25, a 52-week low of $62.34 was recorded on 01/13/25. SMA at 50 days reached $80.23, while 200 days put it at $90.57.

Levels Of Support And Resistance For DXCM Stock

The 24-hour chart illustrates a support level at 86.18, which if violated will result in even more drops to 85.54. On the upside, there is a resistance level at 87.88. A further resistance level may holdings at 88.94. The Relative Strength Index (RSI) on the 14-day chart is 60.57, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.58, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 17.28%. Stochastics %K at 83.53% indicates the stock is a selling.

How much short interest is there in Dexcom Inc?

A steep rise in short interest was recorded in Dexcom Inc stocks on 2025-01-15, dropping by -0.52 million shares to a total of 8.81 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 9.33 million shares. There was a decline of -5.93%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on March 12, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $165 price target.

Most Popular